TREM1 and Sepsis: sTREM-1 as an indicator of TREM-1 activation alongside markedly increased cytokine release could select those patients who would benefit the most from targeted anti-inflammatory or cytokine-reducing therapy—not only in sepsis, but also in other diseases.